Literature DB >> 17052840

Long-term wash-resistant effects of brief interaction of xanomeline at the M1 muscarinic receptor.

Kayla C De Lorme1, Krista L Sikorski, Marianne K O Grant, Esam E El-Fakahany.   

Abstract

Compared to other M(1) muscarinic acetylcholine receptor (M(1) mAChR) agonists, xanomeline demonstrates both reversible and persistent modes of binding to the receptor. In our study, we investigated the long-term consequences of brief incubation of Chinese hamster ovary cells expressing M(1) mAChR (M(1)-CHO) with low concentrations of xanomeline followed by washing off the free drug. Thus, M(1)-CHO cells were exposed to 100 nM xanomeline for 1h then washed extensively. Washed cells were either used immediately for binding assays or incubated for 23 h in the absence of free xanomeline. Only the latter treatment conditions resulted in marked attenuation of binding of the muscarinic radioligand [(3)H]N-methylscopolamine ([(3)H]NMS) to intact cells. Shortening the xanomeline pretreatment period to 1 min had the same trends as the 1h pretreatment, implying that xanomeline binds instantly to the receptor to elicit long-term wash-resistant effects. Presence of atropine during the brief period of xanomeline pretreatment did not markedly modulate xanomeline's long-term effects, which suggests that persistent anchoring of the xanomeline molecule to the M(1) receptor takes place at a site distinct from the orthosteric binding domain. Our findings suggest the possibility of a time-dependent transition of the conformation of the muscarinic M(1) receptor-xanomeline complex between states that vary in their ability to bind [(3)H]NMS. However, possible involvement of other mechanisms of long-term receptor regulation cannot be discounted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17052840      PMCID: PMC1850384          DOI: 10.1016/j.neulet.2006.09.062

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

1.  Discovery of an ectopic activation site on the M(1) muscarinic receptor.

Authors:  Tracy A Spalding; Carol Trotter; Niels Skjaerbaek; Terri L Messier; Erika A Currier; Ethan S Burstein; Donghui Li; Uli Hacksell; Mark R Brann
Journal:  Mol Pharmacol       Date:  2002-06       Impact factor: 4.436

2.  The existence of a second allosteric site on the M1 muscarinic acetylcholine receptor and its implications for drug design.

Authors:  L Michel Espinoza-Fonseca; José G Trujillo-Ferrara
Journal:  Bioorg Med Chem Lett       Date:  2005-12-20       Impact factor: 2.823

3.  Effects of agonist efficacy on desensitization of phosphoinositide hydrolysis mediated by m1 and m3 muscarinic receptors expressed in Chinese hamster ovary cells.

Authors:  J Hu; S Z Wang; E E el-Fakahany
Journal:  J Pharmacol Exp Ther       Date:  1991-06       Impact factor: 4.030

4.  Agonist-induced down-regulation of m1 muscarinic receptors and reduction of their mRNA level in a transfected cell line.

Authors:  S Z Wang; J R Hu; R M Long; W S Pou; C Forray; E E el-Fakahany
Journal:  FEBS Lett       Date:  1990-12-10       Impact factor: 4.124

Review 5.  The potential for muscarinic receptor subtype-specific pharmacotherapy for Alzheimer's disease.

Authors:  M McKinney; J T Coyle
Journal:  Mayo Clin Proc       Date:  1991-12       Impact factor: 7.616

6.  On the unique binding and activating properties of xanomeline at the M1 muscarinic acetylcholine receptor.

Authors:  A Christopoulos; T L Pierce; J L Sorman; E E El-Fakahany
Journal:  Mol Pharmacol       Date:  1998-06       Impact factor: 4.436

7.  Novel persistent activation of muscarinic M1 receptors by xanomeline.

Authors:  A Christopoulos; E E El-Fakahany
Journal:  Eur J Pharmacol       Date:  1997-09-03       Impact factor: 4.432

8.  Allosteric modulation by persistent binding of xanomeline of the interaction of competitive ligands with the M1 muscarinic acetylcholine receptor.

Authors:  Jan Jakubík; Stanislav Tucek; Esam E El-Fakahany
Journal:  J Pharmacol Exp Ther       Date:  2002-06       Impact factor: 4.030

9.  G protein-coupled receptor kinase 5 regulates airway responses induced by muscarinic receptor activation.

Authors:  J K L Walker; R R Gainetdinov; D S Feldman; P K McFawn; M G Caron; R J Lefkowitz; R T Premont; J T Fisher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-10-17       Impact factor: 5.464

10.  Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.

Authors:  H E Shannon; F P Bymaster; D O Calligaro; B Greenwood; C H Mitch; B D Sawyer; J S Ward; D T Wong; P H Olesen; M J Sheardown; M D Swedberg; P D Suzdak; P Sauerberg
Journal:  J Pharmacol Exp Ther       Date:  1994-04       Impact factor: 4.030

View more
  3 in total

1.  Mechanisms of M3 muscarinic receptor regulation by wash-resistant xanomeline binding.

Authors:  Meredith J Noetzel; Marianne K O Grant; Esam E El-Fakahany
Journal:  Pharmacology       Date:  2009-04-28       Impact factor: 2.547

2.  Pharmacological evaluation of the long-term effects of xanomeline on the M(1) muscarinic acetylcholine receptor.

Authors:  Marianne K O Grant; Meredith J Noetzel; Kayla C De Lorme; Jan Jakubík; Vladimír Doležal; Esam E El-Fakahany
Journal:  PLoS One       Date:  2010-12-23       Impact factor: 3.240

3.  Differential regulation of muscarinic M1 receptors by orthosteric and allosteric ligands.

Authors:  Christopher N Davis; Stefania Risso Bradley; Hans H Schiffer; Mikael Friberg; Kristian Koch; Bo-Ragnar Tolf; Douglas W Bonhaus; Jelveh Lameh
Journal:  BMC Pharmacol       Date:  2009-12-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.